Legend Weighted Average Shares Diluted from 2010 to 2023

Stocks . USA . 
Stock . Legend BiotechCorp
LEGN Stock  USD 68.06  2.74  4.19%   
Legend BiotechCorp Weighted Average Shares Diluted yearly trend continues to be very stable with very little volatility. Weighted Average Shares Diluted is likely to drop to about 317.4 M. During the period from 2010 to 2023, Legend BiotechCorp Weighted Average Shares Diluted quarterly data regression pattern had range of 118,083,913 and median of  200,000,000. Legend BiotechCorp Gross Profit is very stable at the moment as compared to the past year. Legend BiotechCorp reported last year Gross Profit of 51.64 Million. As of 6th of June 2023, Interest Expense is likely to grow to about 11.6 M, while Consolidated Income is likely to drop (458.1 M).
  
Check Legend BiotechCorp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Legend main balance sheet or income statement drivers, such as Cost of Revenue of 58.5 M, Gross Profit of 62.4 M or Interest Expense of 11.6 M, as well as many exotic indicators such as Asset Turnover of 0.1, Book Value per Share of 4.09 or Current Ratio of 3.7. Legend financial statements analysis is a perfect complement when working with Legend BiotechCorp Valuation or Volatility modules. It can also supplement Legend BiotechCorp's financial leverage analysis and stock options assessment as well as various Legend BiotechCorp Technical models . Check out the analysis of Legend BiotechCorp Correlation against competitors. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.

Legend BiotechCorp Quarterly Weighted Average Shares Diluted

330.5 Million

Legend Weighted Average Shares Diluted Breakdown

Showing smoothed Weighted Average Shares Diluted of Legend BiotechCorp with missing and latest data points interpolated. The weighted average number of shares or units issued and outstanding that are used by the company to calculate [EPSDil]; determined based on the timing of issuance of shares or units in the period.Legend BiotechCorp's Weighted Average Shares Diluted historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Legend BiotechCorp's overall financial position and show how it may be relating to other accounts over time.
Weighted Average Shares Diluted10 Years Trend
Slightly volatile
Compare to OthersAll Fundamentals
   Weighted Average Shares Diluted   
       Timeline  

Legend Weighted Average Shares Diluted Regression Statistics

Arithmetic Mean225,247,555
Geometric Mean221,589,094
Coefficient Of Variation20.15
Mean Deviation36,067,936
Median200,000,000
Standard Deviation45,395,409
Range118,083,913
R-Value0.77
R-Squared0.60
Significance0.001201
Slope8,382,951

Legend Weighted Average Shares Diluted History

2023317.4 M
2022318.1 M
2021281.7 M
2020236.3 M

About Legend BiotechCorp Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Legend BiotechCorp income statement, its balance sheet, and the statement of cash flows. Legend BiotechCorp investors use historical funamental indicators, such as Legend BiotechCorp's Weighted Average Shares Diluted, to determine how well the company is positioned to perform in the future. Although Legend BiotechCorp investors may use each financial statement separately, they are all related. The changes in Legend BiotechCorp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Legend BiotechCorp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Legend BiotechCorp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Legend BiotechCorp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2023
Weighted Average Shares Diluted318.1 M317.4 M
Average Assets1.2 B1.1 B
Average Equity755.1 M814.7 M
Invested Capital Average315.2 M340.1 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Legend BiotechCorp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out the analysis of Legend BiotechCorp Correlation against competitors. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
CEO Directory
Screen CEOs from public companies around the world
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.25) 
Revenue Per Share
0.639
Quarterly Revenue Growth
(0.12) 
Return On Assets
(0.29) 
Return On Equity
(0.96) 
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY